Airbus delivered the first fully customized ACH145 helicopter to a customer in India, marking a milestone for its corporate aviation division.
The recipient, Adar Poonawalla, is chief executive and executive director of Serum Institute of India, the world’s largest vaccine manufacturer by doses produced.
“We are delighted with our selection of the Airbus ACH145 which is certainly a benchmark in its class," Poonawalla said in a prepared statement. It has been chosen keeping in mind the highest levels of customization, comfort and safety."
Produced by Airbus Corporate Helicopters (ACH), the twin-engine helicopter can seat up to eight passengers and features a Fenestron enclosed tail rotor to reduce noise levels.
The helicopter provides a spacious cabin that can seat up to eight in ACH Line, ACH Mercedes Benz Style or ACH bespoke versions. The ACH145 features Airbus Helicopters’ Helionix avionics, including a standard 4-axis digital Automatic Flight Control System for reduced pilot workload. The Turbomeca Arriel2E engines, with dual channel FADEC, generate 951 shaft horsepower for take-off and allow improved hover and one-engine inoperative performance as well as increased maximum gross weight capability.
“The latest delivery proves once again that Airbus is the only original equipment maker which is able to offer helicopters embedding the highest levels of innovation and end-to-end solutions for the ease of operations of customers,” said Ashish Saraf, head of Airbus Helicopters India & South Asia. “The delivery of this helicopter is an important milestone for us.”
The aircraft will be ready to fly by the end of January, according to Airbus.
In addition to ACH, Airbus owns Airbus Corporate Jets.